Yuya Fujishima Selected Research

Yuya Fujishima Research Topics

Disease

6	Type 2 Diabetes Mellitus (MODY) 11/2023 - 12/2011
6	Obesity 11/2023 - 12/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 02/2014
4	Body Weight (Weight, Body) 06/2023 - 09/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2023 - 04/2013
3	Fibrosis (Cirrhosis) 05/2023 - 01/2020
3	Atherosclerosis 11/2022 - 05/2014
3	Insulin Resistance 01/2022 - 04/2013
3	Inflammation (Inflammations) 01/2022 - 04/2013
3	Heart Failure 10/2020 - 01/2019
2	Hypoxia (Hypoxemia) 01/2024 - 01/2018
2	Non-alcoholic Fatty Liver Disease 07/2023 - 01/2019
2	Weight Loss (Weight Reduction) 01/2023 - 09/2012
2	ST Elevation Myocardial Infarction 12/2022 - 08/2017
2	Atherosclerotic Plaque (Atheroma) 11/2022 - 01/2017
2	Neointima 01/2021 - 01/2017
2	Cardiomegaly (Heart Hypertrophy) 01/2020 - 02/2014
1	Acute Disease 05/2024
1	COVID-19 05/2024
1	Anemia 01/2024
1	Vascular Remodeling 07/2023
1	Liver Diseases (Liver Disease) 02/2023
1	Hypertension (High Blood Pressure) 02/2023
1	Morbid Obesity 01/2023
1	Thrombosis (Thrombus) 11/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Hyperglycemia 01/2022
1	Neoplasms (Cancer) 01/2022
1	Diabetes Mellitus 08/2021
1	Reperfusion Injury 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Ischemia 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Glucose Intolerance 01/2019
1	Vascular System Injuries 01/2017
1	Hypoadiponectinemia 01/2017
1	Arteriosclerosis 01/2015
1	Hypertrophy 02/2014

Drug/Important Bio-Agent (IBA)

16	AdiponectinIBA 05/2024 - 02/2014
5	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 12/2011
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
4	Insulin (Novolin)FDA Link 11/2023 - 09/2012
4	H-cadherin (T-cadherin)IBA 12/2022 - 01/2017
3	Messenger RNA (mRNA)IBA 11/2022 - 04/2013
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2014 - 12/2011
3	Liraglutide FDA Link 01/2014 - 12/2011
2	AdipokinesIBA 05/2024 - 01/2022
2	HypoxanthineIBA 07/2023 - 01/2018
2	Xanthine DehydrogenaseIBA 07/2023 - 02/2023
2	purineIBA 07/2023 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 06/2023 - 01/2019
2	FYX-051IBA 02/2023 - 01/2021
2	MB Form Creatine KinaseIBA 12/2022 - 08/2017
2	CholesterolIBA 11/2022 - 01/2017
2	thiazole-4-carboxamide adenine dinucleotide (TCAD)IBA 01/2021 - 01/2017
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2016 - 12/2011
1	Transcription Factors (Transcription Factor)IBA 01/2024
1	Hypoxia-Inducible Factor 1IBA 01/2024
1	Indicators and Reagents (Reagents)IBA 11/2023
1	Amino Acids FDA Link 11/2023
1	Glutamic Acid (Glutamate)FDA Link 11/2023
1	InflammasomesIBA 05/2023
1	AlbuminsIBA 05/2023
1	Uric Acid (Urate)IBA 02/2023
1	RNA (Ribonucleic Acid)IBA 11/2022
1	ChemokinesIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Claudin-5IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	LigandsIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Transaminases (Aminotransferases)IBA 08/2021
1	CollagenIBA 01/2020
1	DisintegrinsIBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	glycoprotein phospholipase DIBA 01/2019
1	Sucrose (Saccharose)IBA 01/2019
1	DiglyceridesIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Purine NucleotidesIBA 01/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2017
1	CytokinesIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	Angiotensin IIIBA 02/2014
1	CateninsIBA 02/2014
1	EnzymesIBA 01/2014
1	LipidsIBA 01/2014
1	S100 Proteins (S 100 Protein)IBA 04/2013
1	Biomarkers (Surrogate Marker)IBA 12/2011

Therapy/Procedure

4	Therapeutics 02/2023 - 01/2020
4	Glycemic Control 08/2021 - 12/2011
2	Percutaneous Coronary Intervention 12/2022 - 08/2017
1	Nephrectomy 05/2023
1	Gastrectomy 01/2023
1	Bariatric Surgery 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Critical Care (Surgical Intensive Care) 08/2017
1	Diet Therapy (Therapy, Diet) 11/2016